Companies in Dartmouth-Cole Harbour are doing incredible things. From clean tech, to medical and laboratory technology- we have a lot to be proud of.
Yesterday I announced a $500,000 repayable contribution through ACOA’s Business Development Program to Dartmouth’s Precision BioLogic Incorporated!
This funding will support Precision BioLogic’s continuing quest to research and develop improved diagnostic products that can be used in coagulation laboratories to identify disorders more effectively. They’re working on pre-market clearance of an innovative in-vitro diagnostic test to help manage Haemophilia A.
